Kitov Pharmaceuticals Hldgs L Sponsored ADR (KTOV)

[Pennyes]

KTOVs commercial launch of "Consensi" is a positive news for the stock value, its performance will double or triple by this launch alone!, then the two clinical candidates from its Oncology pipeline!....undervalued stock price!??..
================================

Quote:-The projected royalties and milestone revenues from our U.S. marketing and distribution agreements for Consensi(TM), together with the $26 million gross fundraising proceeds we secured this year, will provide the source of financial support for our development efforts aimed at advancing our emerging oncology pipeline, including advancing both NT-219 and CM-24 into significant value creating clinical milestones.